AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms
This study will create a national registry (a secure online database) of people with Noonan syndrome in Italy. Noonan syndrome is a genetic condition. It can affect growth, the heart, and other parts of the body. It is rare, so doctors have limited information about how it develops over time. WHY IS THIS STUDY BEING DONE? The researchers want to learn more about how Noonan syndrome affects people. They will look at: Signs and symptoms of the condition How the specific gene change relates to a person's signs and symptoms How children and adults grow over time Health problems that may appear in the short or long term Growth hormone (GH) treatment: how well it works and how safe it is The researchers will use this information to write advice for long-term care and follow-up. The registry may also make it easier to start future clinical trials for people with Noonan syndrome. WHO CAN TA
Sign in to get the eligibility rules as simple questions to take to your doctor.
…and 27 more on ClinicalTrials.gov.
AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy
HealthTeky